Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 0.43 | $ 82.98M | 1 | 191.55M |
3/31/2025 | $ 0.42 | $ 79.16M | 1 | 190.71M |
12/31/2024 | $ 0.52 | $ 97.37M | 1 | 185.61M |
9/30/2024 | $ 0.57 | $ 106.89M | 1 | 189M |
6/30/2024 | $ 0.65 | $ 122.45M | 1 | 188.04M |
3/31/2024 | $ 0.65 | $ 114.64M | 1 | 175.63M |
12/31/2023 | $ 0.64 | $ 106.02M | 1 | 165.96M |
9/30/2023 | $ 0.71 | $ 119.34M | 1 | 167.51M |
6/30/2023 | $ 0.81 | $ 134.69M | 1 | 166.06M |
3/31/2023 | $ 0.89 | $ 143.91M | 1 | 161.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for ARBUTUS BIOPHARMA CORP is calculated as follows: Equity [ $ 97.34M ] / (Shares WA [ 79.49M ] * Share Factor [ 1 ])
(=) BVPS [ $ 1.22 ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.85 |
average | $ 10.28 |
median | $ 6.03 |
std | $ 12.44 |